Brief: Oasmia Says Finds Novel Candidate For Use In XR-18 Platform

Vivesto AB

24/01/2022 06:01

Jan 24 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * OASMIA ANNOUNCES PROGRESS ON THE DEVELOPMENT OF ITS NEXT
GENERATION XR-18 DRUG DELIVERY TECHNOLOGY
    * HAS IDENTIFIED AND SYNTHESIZED A PROMISING NOVEL CANDIDATE
FOR
USE IN XR-18 DRUG DELIVERY PLATFORM, WHICH IT BELIEVES COULD
OFFER ENHANCED CAPABILITIES COMPARED WITH ITS EXISTING XR-17
TECHNOLOGY

Source text for Eikon:  ID:nMFNbjwWny 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))